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1. Introduction    
Breast cancer, with its uncertain causes and confusion over the best treatments, has 
intrigued the scientific community for years. Numerous resources have been and continue 
to be devoted to research and technical developments to understand its causes, prevention 
and treatment. Despite this, breast cancer still remains the most common malignancy and 
dreaded disease in women in the United States (American Cancer Society [ACS], 2003). 
Progress has been made, nevertheless, in humanizing the horrors that formerly devastated 
the body and psyche (Andersen et al., 2008). 
Anatomically, breasts are hemispherical in shape and are made up of glandular tissues 
embedded in connective tissue which lie over the pectoral muscles. Adipose tissues lie 
between the skin and the glandular tissues, and the size of breasts depend on the adipose 
tissues. As a woman ages, the adipose tissues of the breasts may become more prominent 
than the glandular tissues, and the breasts may become softer and begin to be flaccid. Breast 
cancer is more prevalent in elderly women as they age. The challenges that come with age 
and the aforementioned breast structure complicates the treatment of breast cancer 
particularly with radiation. 
The most common site of breast cancer is the upper outer quadrant followed by the central 
area.  
Curative treatment of breast cancer include combined modality treatment, which 
incorporates surgery (radical or conservative) and adjuvant treatments  such as 
chemotherapy, hormonal therapy, external beam irradiation and brachytherapy 
implantation. The selection of a particular procedure or a combination of procedures 
depends on established prognostic factors such as stage, grade and extension. In general, 
surgery is indicative if the tumor is confined to the breast with no extension through the 
lymphatic system. Brachytherapy implants are used for early stage cancers, either alone or 
in conjunction with external beam radiation therapy. Patients who require breast 
conservation using surgical procedures are often potential candidates for brachytherapy as 
well (Calle et al., 1978; Fisher et al., 1977; Harris et al., 1981; Levene, 1977; Pierquin et al., 
1980; Prosnitz et al., 1977); however, patients with extensive tumors are not good candidates 
for brachytherapy implantation. 
Many women with early-stage breast cancer are treated with breast-conserving surgery 
(lumpectomy) followed by external-beam radiation. The typical radiation course is 
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delivered five days a week for six to seven weeks. A standard "boost" or increased dose to 
the lumpectomy site usually takes an additional one and one-half to two weeks after the 
whole breast is treated with a standard radiation regimen. For the external beam radiation 
treatment to be effective, the geometric  location of the affected breast needs to be 
reproducible (Byhart et al., 1978). Unfortunately, flaccid breasts and the proximity to critical 
healthy organs such as heart and lungs present a great technical challenge even with 
superior immobilization tools (Van Arsdale & Greenlaw, 1971). Postoperative intracavitary 
brachytherapy, delivered twice a day for five days circumvent the technical problems 
experienced with external beam irradiation. This type of treatment is recommendable for 
patients with large breast and/or deep-seated tumors although the available data is not  yet  
enough for analysis to conclusively predict the long term outcomes. 
Volumetric imaging technology with fast automated visualization and geometric 
measurement tools has greatly influenced the current practice of breast brachytherapy. 
Precise details of the tumor or tumor bed help to delineate the area to be treated and to 
determine the necessary margins around the tumor in breast cancer as well as in other 
malignancies (Ricke et al., 2004; Manning, 2001).  
Details of the clinical aspects of breast cancer and its treatment are beyond the scope of this 
chapter. This chapter discusses the physical and technologic aspects of the CT aided breast 
implants using high dose rate (HDR) Iridium-192 afterloading techniques.  
2. Breast cancer diagnosis and tumor localization 
Mammography remains the major and most reliable imaging method used in breast mass 
detection. On a mammogram, breast cancer typically appears as an ill-defined, opacified lesion 
with or without speculated margins (see Figure 1). It can detect small, discrete lesions and 
chest wall involvement. Unfortunately, mammography presents some challenges such as 
discomforts when the breast is compressed between positioning paddle and image receptor 
(see Figure 2), potential image artifacts associated with different breast structures overlying 
each other rendering the tumor difficult to discern, non-differentiation between tumor and 
malignancy, and limitation to only two-dimensional (2D) interpretation of images. 
 
 
Fig. 1. Mammogram showing an ill-defined opacified breast  lesion  
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Fig. 2. Mammography - breast compressed on image receptor   
CT imaging presents a better three-dimensional (3D) understanding of pathological lesions 
when they are present, eliminates the compression and can distinguish between the image 
artifacts and true abnormalities. It is an important tool for the evaluation of local and regional 
disease in selected patients who have an established diagnosis of breast cancer. However, CT 
scanners use x-rays at higher energies than do mammograms, reducing the contrast of the 
images and the ability to distinguish the calcification. For this reason, a CT scanner is less 
efficient than regular mammography at detecting the tiny clusters of calcium (or 
microcalcifications) that can sometimes be indicative of breast cancer (Zwicker et al., 1985). CT 
scanners also have an extra disadvantage of emitting unnecessary radiation exposure to the 
non-targeted parts of the patient. 
A definitive diagnosis of breast cancer can only be made through a microscopic examination of 
breast tissue obtained from a biopsy. As has been aforementioned, breast cancer is currently 
the most common malignancy in women; consequently, development of robust screening and 
detection techniques that can provide earliest diagnosis is necessary since that can lead to cure 
(Henderson, 1980; Schottenfeld et al., 1976). Such systems should be accurate, cost effective, 
and non-invasive and should present three-dimensional visualization of the diseased area. A 
prototype dedicated breast CT has recently been presented (Lindfors et al., 2008). 
3. Postoperative breast brachytherapy irradiation 
Postoperative irradiation of the breast following a breast-conserving surgical procedure to 
remove gross tumor is an example of combined surgical and radiation therapy management 
of local disease. Surgery removes gross tumor while irradiation eradicates subclinical 
disease in the tumor bed (Calle et al. 1986; Fisher, 1986) to reduce local recurrence (Holland 
et al., 1985). 
The disadvantages of external beam irradiation include the time required for protracted 
course of treatment, which can last up to seven weeks, as well as radiation exposure to the 
heart, lung, and normal breast tissue.  The development of high activity artificial isotopes 
(International Atomic Energy Agency [IAEA], 1967; Nath, 1983; Trott 1988), afterloading 
techniques (Almond, 1983; Delcos, 1980; Delcos, 1992; Glasgow,1995; Henschke et al., 1963; 
Hillaris, 1975; Pain, 1972; Syed & Feber 1977; Syed et al., 1977 ), and automated devices with 
remote control has stimulated renewed interest in brachytherapy.  
Brachytherapy can be performed using external surface molds, intracavitary, interstitial, or 
intraluminal techniques or a combination of these methods.  Brachytherapy allows delivery 
of high dose radiation to the tumor while minimizing radiation exposure to normal tissues 
by eliminating the unavoidable transit irradiation occurring with external irradiation, and 
by allowing a highly conformal dose delivery. The radioactive materials used in 
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brachytherapy are of high activity. To allow normal tissue sublethal damage repair, high 
dose rate brachytherapy is generally fractionated. Before each fraction, images are obtained 
to determine the geometry of the radioactive sources and their relationship to anatomic 
targets.  
4. Three-dimensional brachytherapy treatment-planning system 
Treatment planning is often characterized by the dimensionality of the calculation 
algorithm. Two-dimensional algorithms have limited anatomy considerations with limited 
evaluation tools, and in some cases are single point calculations. Three-dimensional 
algorithms depend upon CT-acquired  3D data sets with comprehensive anatomy, can 
model 3D dose corrections and use volumetric evaluation tools. 2D calculations represent 
the dose seen in a single cross sectional slice in an ellipsoid of infinite length and of uniform 
electron density, while 3D algorithms model the dose obtained in actual patient CT data 
sets. 3D treatment planning in brachytherapy is therefore the process by which 3D 
visualization, dose calculation, and plan evaluation tools are used to optimize treatment. 
Tumor size and shape, as well as outlines of anatomic structures, are adequately established 
by the use of CT. Tumors of unusual shape or that are located adjacent to radiosensitive 
tissues benefit from CT based computerized treatment planning.  
The development of 3D brachytherapy treatment planning tools has lagged behind that of 
external beam planning tools. Target definition has traditionally been applicator oriented. 
Technical developments in brachytherapy treatment planning have been mainly oriented 
towards conventional x-ray films and very little towards volumetric sectional imaging. The 
present movement towards 3D image based brachytherapy has been influenced less by the 
procedure itself and largely by the advancements in the 3D imaging equipment and 
computer technology that offers the physicians and the planning team the flexibility of 
understanding the physical aspects of the treatment. McGee and McShan (McGee & 
McShan, 1988) claimed that the breast brachytherapy based on sectional imaging provides a 
major contribution to brachytherapy procedure giving examples of potential impacts based 
on their clinical experience. This experience did not include 3D assessment  of anatomy, 
target, critical organs and 3D image based 3D dose calculations with corresponding display 
and evaluation capabilities according to ICRU report, 50 (ICRU, 1983). Presently, there has 
not been similar frame to what ICRU put down in the report 50 (ICRU, 1983) for breast 
brachytherapy. Calculations based on 2D algorithms ignore the inhomogeneities associated 
with different composition of human tissue, but  with appropriate electron density 
conversions, CT data can be used to perform bulk dose inhomogeneity corrections in 3D 
planning (Almond, 1983).  
The optimal radioactive source dwell locations and dwell durations can be calculated with 
the aid of a treatment planning computer based on the prescribed dose. The treatment 
planning software can optimize these variables once the tumor volume and normal tissues 
and their dose constraints have been delineated by the radiation oncologist.  
3D planning software  uses sophisticated Sievert integral algorithms that break a linear 
radioactive source into tiny components, calculates the dose at every point in the patient 
from every component, and sums these values to get the final result (Edmundson, 1994). 
In keeping with the principles used in 3D external beam radiation planning, breast 
brachytherapy planning begins by delineating the applicator, air pockets and seroma, and 
other critical normal organs such as chest wall, heart, lungs, and skin. Planning treatment 
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volume (PTV) in breast brachytherapy using inflatable balloon applicators requires coverage 
of 1 cm to 2 cm from the applicator which can be constructed using a uniform ring around 
the applicator. 
5. Quality assurance for 3D computer treatment planning system and CT 
It is valuable to scan a simple geometric phantom and send this data through the planning 
process on a weekly or monthly basis. A known phantom geometry should be aligned using 
lasers, scanned, and the images transferred to the computer planning system. Simple 
measuring tools in the planning system can serve as a quick check for geometric distortions, 
image scale, and orientation.  
6. CT based accelerated partial breast irradiation 
To demonstrate the benefits of  the CT image based 3D treatment planning and breast 
brachytherapy, a MammoSite RTS single channel spherical balloon applicator (Cytyc 
Corporation,  Hologic LP, Marlborough, MA 07152 USA) with Varian Brachyvision 3D 
treatment planning system  together with Varian GammaMed Plus ix (Varian Medical 
Systems, Inc, Charlottesville, VA 22903) high dose rate (HDR) afterloader is illustrated. 
6.1 Intraoperative applicator insertion 
MammoSite radiation therapy is a form of accelerated partial breast irradiation (APBI), 
where an afterloading balloon applicator (Figure 3) is inserted directly onto the lumpectomy 
cavity (MammoSite, 2010). 
 
.   
Fig. 3. Deflated MammoSite balloon applicator  
Blue –Fluid port  for balloon water mixture inflation  
Red – Source port  for radioation source wire connector 
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Fig. 4. Dummy source wire with dummy sources 
MammoSite RTS  is suitable for ductal carcinoma in situ, as well as invasive carcinoma 
(Besaleh et al., 2009). The location of the tumor and post-surgical seroma determine whether a 
patient is a candidate for this treatment. The balloon must be at least 5 to 7 mm away from the 
skin, so the technique may not be suitable for small breasted women, or for tumors found near 
the edge of the skin. The lumpectomy cavity must be spherical, or nearly so, in order for the 
balloon to conform to the seroma without air pockets. The cavity must also be large enough to 
allow a balloon volume of at least 30 cc. The balloon is inflated with a dilute mixture of 
iodinated contrast media to allow CT evaluation of balloon position (Souba et al., 2007).  
The MammoSite placement procedure begins by performing the lumpectomy and surgically 
preparing the cavity for MammoSite balloon applicator. The applicator can then be 
implanted at the time of the lumpectomy or post lumpectomy. 
6.2 Breast brachytherapy treatment planning CT images 
Patient data acquisition is an important part of the treatment simulation process, since 
reliable data is required for computerized treatment planning purposes and allows for a 
treatment plan to be properly carried out.  
The patient should be scanned in supine position with hand over the head unless the chest 
wall is involved or is less than 7 mm to the balloon surface. Ideally, the treatment CT 
scanning should be performed 48 hours after the balloon insertion. 
Transverse CT scans contain all information required for complex treatment planning in 
radiation therapy treatment.  
Breast CT scan, with radiographic markers  (see figure 4 with dummy sources) in place, is 
required to verify the patient’s appropriateness for treatment with brachytherapy  and to 
proceed with  3D planning . A slice width of 3 mm is recommended for adequate resolution 
of the applicator and surrounding breast tissue on the acquired axial images as well as 
coronal and sagittal reconstructions.  Pilot or scout films relate CT slice position to anterior-
posterior and lateral radiographic views of the patient at the time of scanning. They are 
obtained by keeping the x-ray source at a fixed position and moving the patient 
(translational motion) through the stationary slit beam. The result is a high definition 
radiograph which diverges on the transverse axis, but does not diverge on the longitudinal 
axis (see Figure 5). The patient image data is then transmitted to the treatment planning 
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computer via either network or portable media using DICOM 2 format or DICOM RT 
format (ICRU, 1999). It is advisable to archive these images as secondary backup should the 
treatment planning computer images be corrupted or be unusable. The conformance of the 
cavity to applicator surface, distance from the balloon applicator surface to skin, and the 
diameter  and symmetry of the applicator then needs to be evaluated either at the CT 
computer or at the treatment planning computer to determine if the treatment can be 
delivered. Ideally, this process should be performed while the patient is still on the CT table 
so that if it is necessary to adjust the balloon volume, this  can still be easily done with a 
follow up CT to confirm the change.  
The minimum balloon’s surface to chest wall/ ribs distance should also be checked to be not 
less than 7 mm.  If it is less than 7 mm, then the patient should be rescanned and treated in 
prone position with the aid of customized breast board immobilizer. 
Figures 6 through 8 and tables 1 through 5 illustrate these parameters for MammoSite RTS 
applicator. 
 
 
Fig. 5. Breast topogram 
 
Orientation Measured, x (mm) x within or  greater than  (5 mm – 7 mm)? Pass/Fail 
Transverse 11.8 Pass 
Frontal 9.7 Pass 
Table 1. Minimum balloon’s surface to skin distance after  consideration of all the CT slices. 
The measurements are a pass if they are within or greater than  5 mm – 7 mm and a Fail 
otherwise. 
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Fig. 6. This figure shows the measured distances from the balloon’s surface to the skin in 
three different orientations. Shown are the CT slices with the shortest distances. Frontal 
view shows the shortest distance of 9.7 mm which is beyond the acceptable minimum 
distance of 5 mm. 
 
 
 
Orientation Diameter, d1 cm Diameter, d2 cm
4.0 ≤ d ≤ 5.0 cm  
Pass/Fail 
Transverse 4.76 4.73 Pass 
Frontal 4.18 4.55 Pass 
 
Table 2. Inflated 4.0  - 5.0 cm MammoSite RTS. The transverse diameter, d cm should range 
between 4 cm to 5 cm to be considered a pass. d1 and d2 represent measurements in 
different directions 
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Fig. 7. This figure shows the measured diameters in three different orientations. Shown are 
the central CT slices with the longest diameters. In this figure, the diameters in all the CT 
views and directions are between 4.0 cm and  5.0 cm and therefore meets the requirements 
for the 4 .0 - 5.0 cm diameter fluid inflated balloon.  
 
 
 
Orientation r1 cm r2 cm I r1 - r2 I cm 
I r1 – r2 I ≤  0.2 cm 
Pass/Fail 
Transverse 2.23 2.40 0. 17 Pass 
Frontal 2.29 2.46 0.17 Pass 
Sagittal 2.17 2.09 0 .08 Pass 
 
Table 3. Evaluation of central lumen asymmetry.  r1 and r2 represent opposing radii. The 
magnitude of the difference should  not be more than 0.2 cm to be considered a pass. 
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Fig. 8. This illustration is for the CT slices showing delineated balloon in three different 
views with the largest diameters. The measurements are made for the opposite radii. The 
maximum differences in the magnitude between the opposing radii in the transverse 
orientation is 1.7 mm which is less than 2.0 mm as required. The bottom right diagram 
exhibits a nearly spherical shape 3D model view of the balloon. 
 
 
 
 
Balloon (cm3) Air (cm3) PTV (cm3) Air/PTV (R)
R ≤ 0.1 
Pass/Fail 
56.9 6.17 164.47 0.038 Pass 
 
 
Table 4. Balloon, Air and PTV computed volumes. R should be less or equal to 0.1 to pass.  
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From table 4, the 3D computed volume is 56.9 cm3 of a nearly spherical balloon. This gives a 
spherical radius of 2.386 cm. From table 3, the average measured radius is 2.27 cm. 
Consequently the measured radius compared to the computed radius differs only by 1.13 
mm which is acceptable. 
6.3 Radiation dose prescription 
MammoSite RTS allows patients to receive their entire treatment in a week, rather than six 
or seven weeks. Patients have two treatments per day with a minimum 6 hour interfraction 
interval, over five treatment days (Radiation Therapy Oncology Group [RTOG], 2009). A 
total dose of 34 Gy is typically prescribed 1 cm from the surface of the balloon. Figure 5 
demonstrates a CT scan which is taken each day of treatment in order to obtain the balloon 
radius, symmetry, and distance from the balloon’s surface to the skin’s surface. 
6.4 3D Computerized treatment planning 
The anatomy based 3D treatment planning is performed using the CT images. These images 
can be fused with images obtained from other modalities such as MRI and PET to clearly 
define the treatment target. The PTV is obtained by first delineating the balloon using 
planning system software tools. The balloon surface is then expanded by 1 cm to obtain an 
expanded volume. Other regions of interest within this expanded volume such as air 
pockets, ribs, lungs, and muscle are then delineated (see figure 9). Skin is created by 
extracting the segmentation from the inner wall of the body by 0.5 cm. These regions 
together with expanded volume lying outside the skin are then removed from the expanded 
volume to obtain the PTV (see Figure 10). 
The air volume within the PTV and PTV volume are then computed. The ratio of the air 
volume to PTV volume should not be more than 0.1. See table 4 for an example on the 
patient specific values. 
The dummy sources in the CT images are also used to determine the single central dwell 
position of the radioactive source in the central lumen (see figure 11). 
This position should be within 2 mm of the balloon center in order to achieve the precision 
of dose to the prescription point within 15% (American Association of Physicists in 
Medicine [AAPM], 1995). Inverse treatment dose computation is then performed on the 3D 
images where prescription volume is used to optimize the source dwell position and 
duration. Figure 12 shows the dose-rate distribution and the dose volume histogram (DVH) 
that is helpful in evaluating the acceptability of the obtained treatment plan. The blue line 
represents 34 Gy prescription isodose line. The DVH (top right portion of figure 12) 
indicates that 34 Gy covers 99.6% of the PTV. It can be noticed from the frontal view that 
part of the skin, which is a normal organ at risk is receiving 39 Gy, more than the prescribed 
dose because of its proximity to the PTV. The ribs and skin should not receive more than 
145% of the prescribed dose. This is an undesirable, but important information that can only 
be obtained from the CT based 3D  treatment plan evaluation. 
6.5 Daily quality control and treatment delivery  
Once an acceptable computerized treatment plan is obtained, a second independent point 
dose is calculated to validate the treatment planning computer generated radioactive source 
dwell durations (American Association of Physicists in Medicine [AAPM], 1995). The 
treatment parameters such as the treatment machine channel number, radioactive source 
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dwell positions and dwell durations are then exported to the treatment delivery computer 
and then checked for deliverability before the patient is actually treated. In the example 
considered above, the measured radius of the balloon is 2.27 cm. The HDR afterloader  
machine used has a combined MammoSite source train (radioactive source transfer tube)  
length of 130.0 cm with 0.5 cm reserved for the catheter tip. This is the combined length of 
the balloon catheter and source guide tube. Therefore the central lumen single  dwell 
position is expected to be located at 127.73 cm. However, for a dwell step size of 0.5 cm, this 
location would be at 127.5 cm.  This value should be compared with the value generated by 
the afterloader  remote control computer before activating the treatment delivery. 
 
 
 
 
Fig. 9. The figure illustrates the  delineated regions of interest. Blue- chest wall, red balloon, 
green- air gap, orange- skin, purple-  expanded balloon. 
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Fig. 10. This figure illustrates PTV with air pockets and a balloon catheter channel. The PTV 
is formed by removing all the regions of interest within the expanded balloon except the air 
pockets. 
Before the first treatment of each day, CT imaging should be repeated to verify balloon 
position and its diameter. If balloon diameter changes by 10% (MammoSite, 2010), balloon 
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integrity must be examined, and a new computerized treatment plan may have to be 
generated.  
The mechanically- controlled motion of the radioactive source from the remote afterloader 
to the balloon applicator is sensitive to the condition of the transfer tube and applicator. 
Daily imaging also aids to assure that there are no kinks or obstructions along the  
transfer tube and applicator situated on the breast to preempt any potential radiation  
safety issue. 
The length and the orientation of the portion of the balloon applicator lying outside the skin 
surface should be checked to be constant before every treatment. Extra syringe should be 
available among the emergency kit to be used for draining and deflating the balloon in case 
of emergency or at the end of the final treatment delivery. The radioactive source transfer 
tube should not pass through the bed rail and the applicator connectors must be thoroughly 
cleaned after every usage following the manufacturers guidelines. 
Figure 13 shows the treatment delivery system which is remotely controlled by the 
treatment delivery computer. 
 
 
Fig. 11. The central radiographic marker (dummy source) is used to determine the central 
location of the single dwell source MammoSite RTS. 
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Fig. 12. 3D Treatment plan evaluation. Central bold green is the simulated radioactive 
source dwell position. Blue line is the 34 Gy prescribed isodose line  
 
 
Fig. 13. Patient undergoing left breast Accelerated Partial Breast  Irradiation using remotely 
computer controlled Varian  Gammamed plus ix HDR  afterloader via MammoSite RTS 
delivery system.  
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7. Conclusion 
CT aided  brachytherapy planning provides advantages over plain radiograph-based 
brachytherapy planning, as individually customized treatment can be obtained with organs 
at risk spared from unnecessary  radiation exposure. CT based 3D treatment planning 
software has improved brachytherapy treatment planning because dose in the target and 
critical organs can be predicted better. CT imaging is also superior when it comes to APBI 
pre-treatment appropriateness evaluation. However, despite the apparent dosimetric 
benefits, there is not yet clear clinical data demonstrating an improved therapeutic ratio. 
Since CT images provide tissue electron density information that can be incorporated into 
3D planning systems, the brachytherapy dose calculation algorithms can now be developed 
further to correct for the tissue heterogeneities to provide more accurate treatments using 
the electron densities.  
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Computed Tomography (CT), and in particular multi-detector-row computed tomography (MDCT), is a
powerful non-invasive imaging tool with a number of advantages over the others non- invasive imaging
techniques. CT has evolved into an indispensable imaging method in clinical routine. It was the first method to
non-invasively acquire images of the inside of the human body that were not biased by superimposition of
distinct anatomical structures. The first generation of CT scanners developed in the 1970s and numerous
innovations have improved the utility and application field of the CT, such as the introduction of helical systems
that allowed the development of the "volumetric CT" concept. In this book we want to explore the applications
of CT from medical imaging to other fields like physics, archeology and computer aided diagnosis. Recently
interesting technical, anthropomorphic, forensic and archeological as well as paleontological applications of
computed tomography have been developed. These applications further strengthen the method as a generic
diagnostic tool for non- destructive material testing and three-dimensional visualization beyond its medical use.
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